Scholars Central

Conference abstractPublished 18 Oct 2018

miR-26a promotes chromosomal instability and breast tumorigenesis

Authors: Leandro Castellano

University of Sussex, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Recently an increasing interest has developed around the therapeutic potential of miRNAs in the cancer clinic. Among several candidates, multiple reports have demonstrated that the use of mimic for the microRNA-26a (miR-26a) could be used for cancer treatment. In fact, transient overexpression of miR-26a has been shown to inhibit G1-S cell cycle progression and promote apoptosis, making it a promising candidate for therapeutic intervention. Remarkably, we demonstrate that miR-26a has a dual-role in breast cancer (BC), due to its ability to both promote and inhibit tumorigenesis. We show that miR-26a not only inhibits G1-S cell cycle phase and tumorigenic proliferation, as previously demonstrated, but also regulates mitosis and cytokinesis and consequently it induces tumorigenesis. Prolonged miR-26a expression acts in this way in both BC cell lines and mouse embryonic fibroblasts (MEFs) demonstrating an important and conserved role of miR-26a in regulating these pathways. To the best of our knowledge this dualrole of a miRNA in promoting/inhibiting the same cancer type has not been demonstrated previously and our findings create significant uncertainty as to the potential use of specific miRNAs as therapeutic targets in cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Leandro Castellano”